Glassman Wealth Services Ngm Biopharmaceuticals Inc Transaction History

Glassman Wealth Services

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.05 - $3.37 $218 - $700	-208 Reduced 69.33%	92 $0
Q2 2023 Aug 08, 2023	SELL	$2.44 - $4.53 $351 - $652	-144 Reduced 32.43%	300 $0
Q1 2023 May 04, 2023	BUY	$3.72 - $5.4 $1,651 - $2,397	444 New	444 $1,000
Q1 2020 May 12, 2020	SELL	$10.0 - $19.51 $150 - $292	-15 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$9.97 - $20.28 $29 - $60	-3 Reduced 16.67%	15 $0
Q3 2019 Nov 01, 2019	BUY	$13.09 - $18.19 $235 - $327	18 New	18 $0

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.